Vor Biopharma VOR Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's accrued expenses?
- Vor Biopharma (VOR) reported accrued expenses of $14.73M in Q1 2026.
- How has Vor Biopharma's accrued expenses changed year-over-year?
- Vor Biopharma's accrued expenses increased by 33370.5% year-over-year, from $44K to $14.73M.
- What is the long-term trend for Vor Biopharma's accrued expenses?
- Over 5 years (2020 to 2025), Vor Biopharma's accrued expenses has grown at a 93.8% compound annual growth rate (CAGR), from $723K to $19.76M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.